Trump administration authorises 172 million barrel SPR drawdown as 32 IEA nations coordinate record emergency oil release
Read More 5 minute read Pharma Industry News JR-446 developed by JCR Pharmaceuticals secures orphan drug designation from the European Commission for MPS IIIB The European Commission has granted orphan drug status to JR-446 for MPS IIIB, supporting JCR Pharmaceuticals’ global rare disease expansion. byPallavi MadhirajuJune 24, 2025